Fed Cir. Judge Newman v. Chief Judge Moore; Update in FTC v. Precision Patient Outcomes, Inc.

U.S. Circuit Judge Pauline Newman v. Chief Judge Kimberly Moore

Without citing any legal authority and prior to the conclusion of any investigation, U.S. Court of Appeals for the Federal Circuit Chief Judge Kimberly Moore has removed fellow U.S. Circuit Judge Pauline Newman from hearing cases for an indefinite period. She has also impeded Judge Newman’s access to chambers phone and computer, and unilaterally decided that the judicial assistant working for Judge Newman “is no longer an employee of the Newman chambers.”

Vec discusses NCLA’s new lawsuit, Newman v. Moore, in the U.S. Court of Appeals for the Federal Circuit.

Update in Federal Trade Commission v. Precision Patient Outcomes, Inc.

The Federal Trade Commission, in its initial filing before the U.S. District Court for the Northern District of California, falsely accused Precision Patient Outcomes, Inc. and CEO Margrett Lewis of unlawfully marketing and selling a dietary supplement called COVID Resist. The problem for FTC is PPO and Ms. Lewis never sold such a product—and FTC knows that. During six months or more of investigation, PPO provided FTC clear proof such sales never happened.

Vec discusses NCLA’s latest counterclaims against the Federal Trade Commission in FTC v. PPO.